[1] FRANGOGIANNIS NG. Fibroblast-Extracellular Matrix Interactions in Tissue Fibrosis. Curr Pathobiol Rep. 2016;4(1):11-18.
[2] 李超然,黄桂林,王帅.间充质干细胞来源外泌体促进损伤组织修复与再生的应用与进展[J]. 中国组织工程研究,2018,22(1):133-139.
[3] BERARDIS S, LOMBARD C, EVRAERTS J, et al. Gene expression profiling and secretome analysis differentiate adult-derived human liver stem/progenitor cells and human hepatic stellate cells. PLoS One. 2014;9(1): e86137.
[4] XU S, LIU C, JI HL. Concise Review: Therapeutic Potential of the Mesenchymal Stem Cell Derived Secretome and Extracellular Vesicles for Radiation-Induced Lung Injury: Progress and Hypotheses. Stem Cells Transl Med. 2019;8(4):344-354.
[5] YAO Y, CHEN R, WANG G, et al. Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium. Stem Cell Res Ther. 2019;10(1):225.
[6] 张登沈,刘达兴,梁贵友.外泌体源性微RNA在心血管疾病发生机制中的研究进展[J].中华医学杂志,2018,98(46):3802-3804.
[7] HURWITZ SN, CONLON MM, RIDER MA, et al. Nanoparticle analysis sheds budding insights into genetic drivers of extracellular vesicle biogenesis. J Extracell Vesicles. 2016;5:31295.
[8] 刘亭亭,贾冬萍,王秀梅.外泌体源性 miRNAs 作为诊断标志物在肿瘤中的研究进展[J].国际遗传学杂志,2019,41(2):143-148.
[9] HOSSEINI SHAMILI F, ALIBOLANDI M, RAFATPANAH H, et al. Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score. J Control Release. 2019;299:149-164.
[10] QU Y, ZHANG Q, CAI X, et al. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation. J Cell Mol Med. 2017;21(10):2491-2502.
[11] XU R, GREENING DW, ZHU HJ, et al. Extracellular vesicle isolation and characterization: toward clinical application. J Clin Invest. 2016;126(4): 1152-1162.
[12] TIAN YF, NING CF, HE F, et al. Highly sensitive detection of exosomes by SERS using gold nanostar@Raman reporter@nanoshell structures modified with a bivalent cholesterol-labeled DNA anchor. Analyst. 2018;143(20):4915-4922.
[13] FUJITA Y, KADOTA T, ARAYA J, et al. Clinical Application of Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapeutics for Inflammatory Lung Diseases. J Clin Med. 2018;7(10):355.
[14] ROCKEY DC, BELL PD, HILL JA. Fibrosis--A Common Pathway to Organ Injury and Failure. N Engl J Med. 2015;373(1):96.
[15] QIN XJ, ZHANG JX, WANG RL. Exosomes as mediators and biomarkers in fibrosis. Biomark Med. 2020;14(8):697-712.
[16] MEYER KC. Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis. Expert Rev Respir Med. 2017;11(5):343-359.
[17] MIKOLASCH TA, GARTHWAITE HS, PORTER JC. Update in diagnosis and management of interstitial lung disease. Clin Med (Lond). 2016; 16(Suppl 6):s71-s78.
[18] SUN L, ZHU M, FENG W, et al. Exosomal miRNA Let-7 from Menstrual Blood-Derived Endometrial Stem Cells Alleviates Pulmonary Fibrosis through Regulating Mitochondrial DNA Damage. Oxid Med Cell Longev. 2019;2019:4506303.
[19] CHOI M, BAN T, RHIM T. Therapeutic use of stem cell transplantation for cell replacement or cytoprotective effect of microvesicle released from mesenchymal stem cell. Mol Cells. 2014;37(2):133-139.
[20] WILLIS GR, FERNANDEZ-GONZALEZ A, ANASTAS J, et al. Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation. Am J Respir Crit Care Med. 2018;197(1):104-116.
[21] SHENTU TP, HUANG TS, CERNELC-KOHAN M, et al. Thy-1 dependent uptake of mesenchymal stem cell-derived extracellular vesicles blocks myofibroblastic differentiation. Sci Rep. 2017;7(1):18052.
[22] LI T, YAN Y, WANG B, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 2013;22(6):845-854.
[23] HYUN J, WANG S, KIM J, et al. MicroRNA125b-mediated Hedgehog signaling influences liver regeneration by chorionic plate-derived mesenchymal stem cells. Sci Rep. 2015;5:14135.
[24] JIANG W, TAN Y, CAI M, et al. Human Umbilical Cord MSC-Derived Exosomes Suppress the Development of CCl4-Induced Liver Injury through Antioxidant Effect. Stem Cells Int. 2018;2018:6079642.
[25] ZHANG W, CHEN XF, HUANG YJ, et al. 2,3,4’,5-Tetrahydroxystilbene-2-O-beta-D-glucoside inhibits angiotensin II-induced cardiac fibroblast proliferation via suppression of the reactive oxygen species-extracellular signal-regulated kinase 1/2 pathway. Clin Exp Pharmacol Physiol. 2012;39(5):429-437.
[26] FENG Y, HUANG W, WANI M, et al. Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One. 2014;9(2):e88685.
[27] ZHAO Y, SUN X, CAO W, et al. Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Acute Myocardial Ischemic Injury. Stem Cells Int. 2015;2015:761643.
[28] ZHANG Z, YANG J, YAN W, et al. Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair. J Am Heart Assoc. 2016;5(1):e002856.
[29] FERGUSON SW, WANG J, LEE CJ, et al. The microRNA regulatory landscape of MSC-derived exosomes: a systems view. Sci Rep. 2018; 8(1):1419.
[30] SHAO L, ZHANG Y, LAN B, et al. MiRNA-Sequence Indicates That Mesenchymal Stem Cells and Exosomes Have Similar Mechanism to Enhance Cardiac Repair. Biomed Res Int. 2017;2017:4150705.
[31] KARANTALIS V, HARE JM. Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res. 2015;116(8):1413-1430.
[32] MEENA AS, SHUKLA PK, SHETH P, et al. EGF receptor plays a role in the mechanism of glutamine-mediated prevention of alcohol-induced gut barrier dysfunction and liver injury. J Nutr Biochem. 2019;64:128-143.
[33] 杨晓颖,朱强强,黄业伟.肾脏纤维化的发病机制及治疗策略研究进展[J].健康之友,2019,30(11):161.
[34] 姚小兵.肾纤维化的发病机制及治疗研究进展[J].国际泌尿系统杂志,2019,39(2):371-374.
[35] LIU F, ZHUANG S. New Therapies for the Treatment of Renal Fibrosis. Adv Exp Med Biol. 2019;1165:625-659.
[36] WANG B, YAO K, HUUSKES BM, et al. Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis. Mol Ther. 2016;24(7):1290-1301.
[37] WANG H, WANG B, ZHANG A, et al. Exosome-Mediated miR-29 Transfer Reduces Muscle Atrophy and Kidney Fibrosis in Mice. Mol Ther. 2019; 27(3):571-583.
[38] ZHU F, CHONG LEE SHIN OLS, Pei G, et al. Adipose-derived mesenchymal stem cells employed exosomes to attenuate AKI-CKD transition through tubular epithelial cell dependent Sox9 activation. Oncotarget. 2017;8(41):70707-70726.
[39] EBRAHIM N, AHMED IA, HUSSIEN NI, et al. Mesenchymal Stem Cell-Derived Exosomes Ameliorated Diabetic Nephropathy by Autophagy Induction through the mTOR Signaling Pathway. Cells. 2018;7(12):226.
[40] NAGAISHI K, MIZUE Y, CHIKENJI T, et al. Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes. Sci Rep. 2016;6:34842.
[41] 胡玉燕,尹磊,张晨笑,等.脐带间充质干细胞外泌体对大鼠肾间质纤维化的抑制作用[J].江苏大学学报(医学版),2020,30(4):282-286.
[42] 张林,王帅,张霓霓,等.脱细胞基质制备方法及其在涎腺组织工程中的应用[J].中国组织工程研究,2020,24(10):1597-1603.
[43] VAN LUIJK P, PRINGLE S, DEASY JO, et al. Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer. Sci Transl Med. 2015;7(305): 305ra147.
[44] EGGENHOFER E, BENSELER V, KROEMER A, et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol. 2012;3:297.
[45] 代敏,王帅,张霓霓,等.低氧预处理人羊膜间充质干细胞的生物学特征[J].中国组织工程研究,2021,25(19):3004-3008.
[46] 王英鑫.低氧预处理人羊膜间充质干细胞修复放射性涎腺损伤功能的研究[D].遵义:遵义医学院,2018.
|